Reference
NICE. Around 10,000 people could benefit from new migraine drug as NICE says it?s cost-effective. Internet Document : 12 Mar 2020. Available from: URL: https://www.nice.org.uk/news/article/around-10-000-people-could-benefit-from-new-migraine-drug-as-nice-says-it-s-cost-effective
Rights and permissions
About this article
Cite this article
UK NICE recommends fremanezumab for chronic migraine prevention. PharmacoEcon Outcomes News 849, 37 (2020). https://doi.org/10.1007/s40274-020-6688-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6688-6